Myopia control spectacles

DEVICE2 trials

Sponsors

Dopavision GmbH, CooperVision, Inc.

Conditions

Myopia

Unknown Phase

MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation

CompletedNCT04967287

Dopavision GmbHMyopia

Start: 2021-11-16End: 2024-10-04Updated: 2024-10-28

Investigation of Wearing Compliance of Spectacles for Myopia Control

CompletedNCT06590441

CooperVision, Inc.Myopia

Start: 2024-09-30End: 2025-01-18Updated: 2025-11-25

Related Papers

MyopiaX-1 Safety and Efficacy of a Novel Approach to Slow Juvenile Myopia Progression: A Multicenter, Randomized, Controlled Trial.

2025-10-10